Mitigating peritoneal membrane characteristics in modern peritoneal dialysis therapy

被引:52
|
作者
Davies, S. J.
机构
[1] Univ Hosp N Staffordshire, Dept Nephrol, Stoke On Trent ST4 7LN, Staffs, England
[2] Univ Keele, Inst Sci & Technol Med, Keele ST5 5BG, Staffs, England
关键词
solute transport; ultrafiltration capacity; patient survival; Stoke PD Study; icodextrin; automated peritoneal dialysis (APD);
D O I
10.1038/sj.ki.5001920
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Membrane function at the start of peritoneal dialysis (PD) treatment, measured as solute transport rate and ultrafiltration capacity, varies considerably between individuals. Although this can be correlated to clinical factors such as age and body habitus, this accounts for little of the variance seen. It is increasingly clear, however, that this variability in membrane function does impact on clinical outcomes. Specifically, high solute transport increases mortality risk, independent of other known factors such as age, comorbidity, and residual renal function. High solute transport causes earlier loss of the osmotic gradient when a low molecular weight osmolyte such as glucose is used. This will result in an earlier and lower peak in the ultrafiltration achieved combined with a higher fluid absorption rate once the osmotic gradient is lost. It is therefore quite plausible that the worse clinical outcomes associated with high transport reflect less good ultrafiltration, although other explanations must be considered, including higher peritoneal protein losses and a possible association with systemic inflammation. Strategies now exist to mitigate the effects of high transport on fluid removal. These include optimization of the short dwell lengths using automated PD (APD) combined with icodextrin which will result in sustained ultrafiltration and thus prevention of reabsorption in the long dwell. Survival analysis of APD patients, especially in cohorts in which icodextrin has been used, would suggest that high transport status is not a risk factor, although some of these data are only preliminary. In contrast, low ultrafiltration capacity of the membrane seems to be more important in these patients, especially if anuric. Here the best strategy would seem to be prevention as patients who develop low ultrafiltration capacity are not easily treated on PD. Avoiding excessive hypertonic glucose exposure and preserving residual renal function offers the best available approach.
引用
收藏
页码:S76 / S83
页数:8
相关论文
共 50 条
  • [1] Peritoneal Membrane Characteristics in Patients on Peritoneal Dialysis
    Al-Wakeel, Jamal
    Al-Ghonaim, Mohammad
    Al-Suwaida, Abdulkareem
    Askar, Akram
    Usama, Saira
    Feraz, Niaz
    Shah, Iqbal Hamid
    Memon, Nawaz
    Qudsi, Abdo
    Sulaimani, Fathia
    [J]. SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2011, 22 (01) : 49 - 53
  • [2] The peritoneal membrane in chronic peritoneal dialysis
    Krediet, RT
    Madias, NE
    Plum, J
    Schlöndorff, DO
    Ittel, TH
    Jörres, A
    Berden, JHM
    Gross, P
    Passlick-Deetjen, J
    Wetzels, JF
    Messner, H
    Pommer, W
    Sterzel, RB
    [J]. KIDNEY INTERNATIONAL, 1999, 55 (01) : 341 - 356
  • [3] Peritoneal membrane failure in peritoneal dialysis patients
    Krediet, RT
    van Esch, S
    Smit, W
    Michels, WM
    Zweers, MM
    Ho-dac-Pannekeet, MM
    Struijk, DG
    [J]. BLOOD PURIFICATION, 2002, 20 (05) : 489 - 493
  • [4] The Peritoneal Membrane and Its Role in Peritoneal Dialysis
    Morelle, Johann
    Lambie, Mark
    Oberg, Carl M.
    Davies, Simon
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 19 (02): : 244 - 253
  • [6] The role of peritoneal dialysis in modern renal replacement therapy
    Goodlad, Catriona
    Brown, Edwina
    [J]. POSTGRADUATE MEDICAL JOURNAL, 2013, 89 (1056) : 584 - 590
  • [7] Peritoneal dialysis in the modern era
    Karkar, Ayman
    Wilkie, Martin
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 2023, 43 (04): : 301 - 314
  • [8] Pathophysiological Mechanisms of Peritoneal Fibrosis and Peritoneal Membrane Dysfunction in Peritoneal Dialysis
    Ito, Yasuhiko
    Sun, Ting
    Tawada, Mitsuhiro
    Kinashi, Hiroshi
    Yamaguchi, Makoto
    Katsuno, Takayuki
    Kim, Hangsoo
    Mizuno, Masashi
    Ishimoto, Takuji
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)
  • [9] Inflammatory Effects of Dialysis Solutions on Peritoneal Membrane in Peritoneal Dialysis Patients
    Isvoranu, Iuliana
    Peride, Ileana
    Radulescu, Daniela
    Niculae, Andrei
    Sinescu, Ruxandra Diana
    Checherita, Ionel Alexandru
    [J]. REVISTA DE CHIMIE, 2015, 66 (09): : 1316 - 1320
  • [10] Peritoneal-Membrane Characteristics and Hypervolemia Management in Peritoneal Dialysis: A Randomized Control Trial
    Li, Szu-Yuan
    Chuang, Chiao-Lin
    Lin, Chih-Ching
    Tsai, Shin-Hung
    Chen, Jinn-Yang
    [J]. MEMBRANES, 2021, 11 (10)